Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

How Is Pfizer's Stock Performance Compared to Other Pharmaceuticals Stocks?

Pfizer has underperformed the pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

3 Gene Therapy Stocks With Game-Changing Potential

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, investing in gene therapy stocks like Pfizer (PFE), Sanofi (SNY), and Novartis AG (NVS) could be beneficial. Read on….

StockNews.com

Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

Latin Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer CEO Booed At White House Event

President Trump's praise of Pfizer CEO at Black History Month event sparks mixed audience reactions due to company's Covid-19 vaccine controversy.

Top News

Is This Dividend Stock a Buy After Better-Than-Expected Q4 Results?

Upcoming clinical trial results will give investors a much better look into Pfizer’s operational health.

Barchart

Joe Montana On Brock Purdy's Future, Notre Dame, and 49ers' Window

Football legend Joe Montana joins SI's Claudette Montana, on behalf of Pfizer, to discuss Brock Purdy's future in San Francisco, Marcus Freeman and Notre Dame,

Sports Illustrated

Pfizer's Super Bowl 2025 Ad Featuring Young Cancer Survivor Sparks Mixed Reactions

Pfizer's Super Bowl ad received mixed reactions on social media, but many criticized the pharma giant for saying it will "knock out" cancer amid concerns over its COVID-19 vaccine.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Big tech will spend a staggering amount on AI in 2025

The four biggest tech companies will spend more on capital projects this year than the combined market value of Pfizer and Citigroup.

The Street

Stock Market Sideways Amid Trump Tariff, Inflation Fears; Palantir, Google, Amazon Among Key Movers: Weekly Review

The stock market was up and down with Trump tariff fears in focus. Palantir led big earnings winners. Google and Amazon were losers.

Investors Business Daily

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Fortune

Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says

Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they try to do’

The Independent UK

Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?

Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.

Investors Business Daily

Dow Jones Falls On Trump Tariff News; Palantir Surges 27% On Earnings

The Dow Jones dropped Tuesday as China imposed tariffs on U.S. imports in response to President Trump's tariffs. Palantir surged on earnings.

Investors Business Daily

Stock Index Futures Slip on Trade War Concerns, U.S. JOLTs Report and Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stock Index Futures Muted Ahead of U.S. JOLTs Report and Fed Speak, Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Barchart

Option Volatility And Earnings Report For February 3 - 7

Last week was extremely busy on the earnings front, so this week is a little more sedate. That being said, we still have some big names due to report including Amazon, Alphabet, Walt Disney, Palantir Technologies, Advanced Micro Devices, Microstrategy, Uber Technologies and Pfizer.

Fortune

Major players in the anti-DEI movement: Here's who's pressuring Goldman Sachs, Pfizer, IBM, and other Fortune 500 companies to drop their policies

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in corporate America.

The Guardian - UK

What has the UK Covid inquiry learned so far about vaccines and treatments?

In fourth part of the inquiry, questons were asked about vaccine trials, procurement and the UK’s preparedness for future pandemics

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Pfizer Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Pfizer trailing behind the broader market over the past year, Wall Street analysts remain moderately bullish about the stock's potential.

The Guardian - US

RFK Jr’s shifting vaccines stance worries experts ahead of confirmation hearing

Anti-vaccine rhetoric has been a lucrative enterprise for RFK Jr – one he is now trying to distance himself from

Investors Business Daily

Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now

Pfizer stock bounded off its 50-day line on Monday after avoiding a battle with activist investor Starboard Value — for now.

Top News

Pfizer To Pay Million In Kickback Scheme Settlement

Pfizer settles million over kickbacks for Nurtec ODT prescriptions; whistleblower rewarded.

The Conversation

People on Ozempic may have fewer heart attacks, strokes and addictions – but more nausea, vomiting and stomach pain

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.

Kiplinger

Qorvo Stock Pops After Starboard Takes a Stake in the Apple Supplier: What to Know

Qorvo stock is soaring Friday after activist investor Starboard Value disclosed a new stake in the Apple supplier. Here's what investors need to know.

Barchart

This Dividend Stock Has Plunged Ahead of Trump’s Inauguration. Here Are 3 Reasons Investors Should Still Buy It.

For savvy investors, Pfizer could be an undervalued stock to buy here.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations